Medical Assessor - £81,000-£117,800 p.a. + benefits

Medical Assessor - £81,000-£117,800 p.a. + benefits - Civil Service Jobs - GOV.UK You need JavaScript enabled to use this service. Cookies on Civil Service Jobs We'd like to use analytics cookies so we can understand how you use Civil Service Jobs and make improvements. We also use essential cookies to remember if you’ve accepted analytics cookies. Your cookie preferences have been set You have chosen to accept analytics cookies. You will be asked for your preferences again in 90 days. You can change your cookie settings at any time. Your cookie preferences have been set You have chosen to reject analytics cookies. You will be asked for your preferences again in 90 days. You can change your cookie settings at any time. Skip to main content GOV.UK Civil Service Jobs Beta Your feedback will help us to improve. Home Sign in to your account Cymraeg Medical Assessor - £81,000-£117,800 p.a. + benefits Medicines and Healthcare Products Regulatory Agency Apply before 11:55 pm on Sunday 11th October 2026 Return to search results Details Reference number 483114 Salary £81,000 - £117,800 New entrants to the Civil Service will start their role on the salary band minimum. A Civil Service Pension with an employer contribution of 28.97% GBP Job grade SCS Pay Band 1 Contract type Permanent Business area MHRA - Healthcare, Quality and Access Group Type of role Other Working pattern Flexible working, Full-time Number of jobs available 5 Contents Location About the job Benefits Things you need to know Apply and further information Location London, London (region), E14 5 About the job Job summary We are currently looking for Medical Assessors to join our Innovative Medicines function within the Healthcare Quality and Access Group. This is a full-time opportunity, on a permanent basis. The role will be based in 10 South Colonnade, Canary Wharf London, E14 4PU . The Medicines and Healthcare products Regulatory Agency enhance and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research. The objective of the Healthcare Quality and Access portfolio is to drive quality and critically appraise benefits and risks to inform robust decisions on healthcare access including accelerated access pathways. It will do this by bringing together a fusion of our capabilities across both medicines and medical devices to enable licensing and market access, as well as ensurin